Yuri Jung

Statistics

Publications

Citations

205

H-Index

Active since

2013

Affiliations

Korea Research Institute of Bioscience and Biotechnology(Current)

Korea University of Science and Technology

Asan Medical Center

University of Ulsan

Ulsan College

Yuri Jung is an author at Korea Research Institute of Bioscience and Biotechnology specializing in molecular oncology, oncology, and metabolic reprogramming.

ORCID

Publications per year

2013–2021

Publications

Pyruvate kinase isoenzyme M2 is a therapeutic target of gemcitabine-resistant pancreatic cancer cells

Dong Joon Kim, Young Soo Park, Mingu Kang et al. · Experimental Cell Research · 2015 · 78 citations

Medicine, Biochemistry, Oncology +14

AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth

Young Soo Park, Dong Joon Kim, Han Koo et al. · Oncotarget · 2016 · 52 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

A Novel Pyruvate Kinase M2 Activator Compound that Suppresses Lung Cancer Cell Viability under Hypoxia

Dong Joon Kim, Young Soo Park, Nam Doo Kim et al. · Molecules and Cells · 2015 · 32 citations · Full text

Medicine, Molecular Biology, Oncology +17

The inhibitory effect of a synthetic compound, (Z)-5-(2,4-dihydroxybenzylidene) thiazolidine-2,4-dione (MHY498), on nitric oxide-induced melanogenesis

So Hee Kim, Yeon Ja Choi, Kyoung Mi Moon et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 19 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Metabolic Signature Genes Associated with Susceptibility to Pyruvate Kinase, Muscle Type 2 Gene Ablation in Cancer Cells

Yuri Jung, Ye Jin Jang, Min Ho Kang et al. · Molecules and Cells · 2013 · 14 citations · Full text

Life Sciences, Genetics, Oncology +17

1–5 of 6